|
Volume 271,
Number 21,
Issue of May 24, 1996 pp. 12185-12190
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
A Di-hydrophobic
Leu-Val Motif Regulates the Basolateral Localization of CD44 in
Polarized Madin-Darby Canine Kidney Epithelial Cells (*)
(Received for publication, December 26, 1995)
Humma
Sheikh (§),
,
Clare M.
Isacke
From the Department of Biology, Imperial College of Science, Technology and
Medicine, Prince Consort Road, London SW7 2BB, United Kingdom
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Both in vivo and in vitro the distribution of
the resident plasma membrane adhesion protein, CD44, is restricted to
the basolateral domain of polarized epithelial cells, suggesting a role
in interepithelial interactions. To determine how this localization
might be regulated, a range of CD44 cytoplasmic domain mutations were
generated and a minimal 5 amino acid sequence,
His -Leu-Val-Asn-Lys , was identified which
when deleted results in expression of CD44 on the apical microvillal
membrane. Further mutagenesis throughout this regions pinpointed a
critical di-hydrophobic motif, Leu /Val . The
ability of wild type but not mutant CD44 cytoplasmic domains to
redirect an apically targeted protein, placental alkaline phosphatase,
to the basolateral plasma membrane demonstrates that this sequence can
function as a dominant localization signal. This
His -Lys sequence is spatially
separate from other CD44 regulatory elements and as discussed here, a
comparison with known basolateral sorting sequences identified in other
transmembrane proteins suggests that a distinct mechanism operates to
retain resident plasma membrane proteins in their correct plasma
membrane subdomains.
INTRODUCTION
CD44 was originally identified as an abundant 80-100-kDa
transmembrane glycoprotein on a variety of cell types. In recent years,
much of the interest in CD44 has stemmed from experiments demonstrating
that it is a principle receptor for the important extracellular matrix
glycosaminoglycan, hyaluronan, and that inappropriate expression can
result in increased tumor growth and metastasis (reviewed in Refs. 1
and 2). However, although enhanced levels of CD44 expression and/or
alterations in CD44 splicing are frequently found in epithelial tumors,
little is known about the function and regulation of this adhesion
protein in epithelial cells. In stratified epithelia such as the skin,
abundant CD44 is found in the basal and spinous layers co-localized
with its ligand, hyaluronan(3, 4, 5) , and an
interaction between CD44 and hyaluronan mediates cell:cell adhesion
between keratinocytes(6, 7) . A different picture
emerges in simple epithelia such as that in the gastrointestinal tract
where CD44 is found only on the dividing cells within the crypts of
Lieberkühn. In these cells abundant CD44 is found
on the lateral plasma membranes, but no intercellular hyaluronan is
detected(3) . This raises the possibility that in simple
epithelia CD44 may have a role in hyaluronan-independent intercellular
interactions. Polarized epithelia have two compositionally and
morphologically distinct cell surface domains reflecting their
disparate functions (reviewed in (8) and (9) ). The
upper apical microvillal surface provides a protective role by acting
as a barrier between the external and internal environments and it
contains the necessary transporters for the uptake of small molecules.
The basolateral surface is involved in cell:cell and cell:matrix
adhesion and also contains plasma membrane proteins involved in signal
transduction and nutrient uptake. Generation and maintenance of these
two domains is required for the correct functioning of polarized cells
and involves the continuous sorting and correct plasma membrane
insertion of newly synthesized proteins. In addition, the ability of
mature proteins presented at the plasma membrane to be endo- and
transcytosed must be strictly regulated (reviewed in (10, 11, 12, 13) ). In the studies
described here we have employed the well characterized MDCK cell line
which can be grown to confluence to generate a functional polarized
monolayer. In these cells CD44 is localized exclusively to the lateral
plasma membrane (14) supporting the in vivo data for a
role of CD44 in interepithelial interactions. As has been demonstrated
for a number of other transmembrane
receptors(15, 16, 17) , the basolateral
localization of CD44 is regulated by the cytoplasmic domain in that the
truncation of this domain results in a tailless (T-) ( )molecule which is localized to the apical microvillal
membrane(14) . However, unlike these well characterized
transmembrane receptors, CD44 is a long lived resident plasma membrane
protein that is not subject to rapid endo- or
transcytosis(14, 18, 19, 20, 21, 22) .
This manuscript describes experiments identifying a specific sequence
motif within the CD44 cytoplasmic domain that regulates the correct
localization of this protein in polarized epithelial cells. These
results provide insight into the regulation of this important adhesion
protein which has been strongly implicated to play a role in epithelial
disease progression. Furthermore, these studies provide clues as to the
mechanisms controlling the trafficking and stabilization of resident
membrane proteins in polarized cells.
MATERIALS AND METHODS
Generation of CD44 Cytoplasmic Domain
MutantsThe isolation of a human CD44 cDNA clone containing none
of the alternatively spliced exons(23) , the generation of the
T- CD44, and the insertion of these cDNA clones into pUC19 vector,
pSELECT mutagenesis vector, and pSR -neo eukaryotic expression
vector have been described previously(14, 24) . To
generate the Ser -Thr cytoplasmic
domain deletion, a previous mutant Ala CD44 (24) in the pSR -neo expression vector was employed.
Generation of the Ala CD44 mutant created a novel PvuII restriction site. pSR -neo/Ala CD44
was digested with BstXI, and the linearized vector and a
411-base pair (bp) BstXI fragment were isolated and purified.
The 411-bp fragment was then restricted with PvuII to give
255-, 90-, and 66-bp fragments. Linearized vector along with the 255-
and 66-bp fragments were ligated together. The loss of the 90-bp
fragment results in a deletion of 30 amino acids from
Ala -Thr inclusive.To generate the
Gly -Pro mutant, the same
restriction strategy as described above was employed. Following the PvuII digestion the 255-bp fragment was discarded and the 90-
and 66-bp fragments were purified. pUC19/WT CD44 was restricted with MboII producing a 256-bp fragment, which was isolated and
purified. This 256-bp fragment was then treated with the Klenow
fragment of DNA polymerase 1 and dNTPs to fill in overhanging ends and
then restricted with BstXI generating two fragments of 196 and
60 bp. The 196-bp fragment was retained and ligated along with the 90-
and 66-bp PvuII fragments into the BstXI linearized
pSR -neo/Ala CD44 vector to generate a 20-amino acid
deletion from Gly -Pro . The
following oligonucleotides (see Table 1) were used for loop out
or point mutagenesis with WT CD44 in the pSELECT vector (Promega) as a
template. C15 for Gly -Ser , C14
for Lys -Val , C12 for
His -Ser , C11 for
Glu -Thr , C21 for
His -Lys , C22 for
Gln -Ser , C19 for
Ala , C25 for Ala , C23 for
Ala /Ala . All mutants generated in the
pSELECT vector were excised and subcloned into the pSR -neo
eukaryotic expression vector, as described previously(24) .
The Ala , Ala , and Ala mutants were generated by a two round polymerase chain reaction
mutagenesis strategy, using C24, C18, and C20 mutagenic
oligonucleotides, respectively, as primers. The first round was primed
with C18, C20 or C24, and C4, the template used was pUC19/CD44. The
product was purified, denatured by heating, and used with primer C3 in
a second round polymerase chain reaction using the same template. The
product was then isolated, purified, Klenow-treated, and ligated into
end-polished BamHI restricted pSR -neo expression vector.
The identity of all mutant clones was confirmed by restriction
endonuclease digestion and DNA sequencing.
Generation of PLAP/CD44 ChimerasThe transmembrane
and cytoplasmic domains of WT CD44, T- CD44,
His -Ser CD44 and
Ala /Ala CD44 were polymerase chain
reaction-amplified using high fidelity Pfu DNA polymerase
(Stratagene) and primers C32 and C4. Each product was end polished and
ligated into the unique HindIII site of the pBC12/PLAP 489
vector(16) . The entire PLAP/CD44 chimera was then amplified
using Pfu DNA polymerase and primers C40
(5`-GCCCTCCAGACATGCTGGGG-3`, corresponding to bases 28-47 of
human PLAP; (25) ) and C4, end-polished, and ligated into BamHI restricted, end-polished pSR -neo expression vector.
The identity of all mutant clones was confirmed by restriction
endonuclease digestion and DNA sequencing.
Expression and Analysis of CD44 Cytoplasmic Domain
Mutants and PLAP/CD44 Chimeras in MDCK CellsCD44 cytoplasmic
domain mutants in the pSR -neo vector were transfected into MDCK
cells by electroporation and clonal lines expressing human CD44
selected and maintained as described previously(14) . PLAP/CD44
chimeras were electroporated into MDCK cells, and protein expression in
G418-resistant mixed populations was detected using a rabbit anti-PLAP
antiserum (Dako). MDCK cells were cultured as confluent polarized
monolayers on Transwell filters, the integrity of the tight junctions
was tested and the distribution of CD44 mutants and PLAP/CD44 chimeras
determined by confocal microscopy and cell surface biotinylation as
described previously (14) using the anti-human CD44 mAb, E1/2,
or the anti-PLAP antiserum, respectively. The percentage of proteins in
bands from the autoradiograms was quantitated by scanning densitometry
with a UVP scanner in conjunction with a gel analysis program for
Windows 3.1.
RESULTS
Polarized Expression of Cytoplasmic Deletion Mutants of
CD44CD44 is subject to extensive alternative splicing due to
the variable insertion of 10 exons into a single extracellular membrane
proximal site(23, 26) . Although there are potentially
numerous CD44 isoforms all of these proteins contain a common
intracellular domain. In all of the experiments described here, a CD44
clone encoding the human CD44H isoform that contains none of these
variant exons was employed. To identify a potential basolateral
determinant contained within the CD44 cytoplasmic domain, a series of
internal cytoplasmic deletion mutants were generated (Fig. 1),
and single cell clones of MDCK cells expressing mutant proteins were
isolated. Clonal cell lines were cultured as functional polarized
monolayers on Transwell filters and the distribution of transfected
human CD44 examined by confocal microscopy using mAb E1/2, which is
specific for human CD44 (Fig. 2). A mutant containing a deletion
in the membrane proximal part of the cytoplasmic domain,
Gly -Pro CD44, had a distribution
indistinguishable from WT CD44 in that essentially all of the protein
was tightly restricted to the lateral plasma membrane (Fig. 2, a and c; (14) ). In contrast, removal of the
adjacent downstream 30 amino acids
( Ser -Thr ) resulted in a mutant
protein that was localized to the apical plasma membrane with a
proportion observed intracellularly (Fig. 2, b and d). This distribution was reminiscent of that found with a
truncated T- CD44 in which only three membrane proximal arginine
residues remain in the cytoplasmic tail (Fig. 1; (14) and (24) ). By generating smaller deletions within
this Ser -Thr 30-amino acid segment,
it was demonstrated that removal of an 8-amino acid sequence
( His -Ser ) gave a mutant protein
with a T- CD44 localization pattern (Fig. 2g), whereas
removal of residues upstream
( Gly -Ser , Fig. 2e;
Lys -Val , Fig. 2f) or downstream
( Glu -Thr , Fig. 2h) generated mutant proteins with a WT CD44
localization pattern. A comparison of the
His -Ser amino acid sequence between
the eight species sequenced to date (22, 52) revealed
that residues His -Lys are completely
conserved, Glu is changed to a glycine in bovine CD44,
Ser is changed to proline in a number of species, and
Ser is changed to threonine in the rat. Consequently two
further deletions were generated in this region,
His -Lys and
Glu -Ser . By confocal microscopy,
the Glu -Ser mutant behaved like
WT CD44 (Fig. 2j), whereas the
His -Lys mutant resembled a T-
CD44 (Fig. 2i).
Figure 1:
Deletion mutations in the cytoplasmic
domain of human CD44. Mutations were generated as described under
``Materials and Methods.'' Amino acid numbers are as
according to Stamenkovic et
al.(27) .
Figure 2:
Distribution of CD44 cytoplasmic domain
deletion mutants in polarized MDCK cells. Clonal lines of MDCK cells
expressing Gly -Pro (a,
c), Ser -Thr (b, d)
Gly -Ser (e),
Lys -Val (f),
His -Ser (g),
Glu -Thr (h),
His -Lys (i), and
Glu -Ser (j) human CD44
were grown to confluence on Transwell filters. Cells were fixed,
permeabilized, and incubated with the anti-human CD44 mAb, E1/2,
followed by rhodamine-conjugated anti-mouse Ig and visualized by
confocal microscopy. a and b show horizontal xy
sections through the cells. c-j show vertical xz
sections taken in 0.2-µm steps through the cells with the apical
plasma membrane of the cells orientated topmost. Bar, 10
µm.
To confirm and quantify the
distribution of these CD44 cytoplasmic deletion proteins in epithelial
cells, clonal MDCK cell transfectants were cultured on duplicate
Transwell filters, the integrity of the monolayer was assessed by
[ H]inulin testing, and then cells were
surface-biotinylated from either the apical or basolateral side. In
agreement with the confocal data, it was found that in those mutants
with a WT CD44 localization pattern, less than 13% of the CD44 was
accessible to biotinylation on the apical plasma membrane, and
conversely, in those mutants whose cell surface localization resembled
T- CD44, greater than 88% of the CD44 could be labeled by apical
biotinylation (Fig. 3).
Figure 3:
Cell
surface biotinylation of CD44 deletion mutants in polarized MDCK cells.
Clonal lines of MDCK cells expressing WT (a), T- (b),
Gly -Pro (c),
Ser -Thr (d)
Gly -Ser (e),
Lys -Val (f),
His -Ser (g),
Glu -Thr (h),
His -Lys (i), or
Glu -Ser (j) human CD44
were grown to confluence on duplicate Transwell filters and
biotinylated either from the apical (A) or from the
basolateral (B) sides. Transfected CD44 was immunoprecipitated
with mAb E1/2, resolved on a 10% polyacrylamide gel, and blotted onto
nitrocellulose. Biotinylated protein was visualized using horseradish
peroxidase-streptavidin and the ECL reagent. The percentage of
biotinylated CD44 expressed apically is shown. Blots were exposed to
x-ray film for 1 min. Molecular size markers are in
kilodaltons.
Basolateral Localization of CD44 Requires a
Di-hydrophobic Amino Acid MotifTo further characterize the
sequence required for the basolateral localization of CD44, amino acids
His to Lys were changed individually to
alanine residues (Fig. 4a), and clonal cell lines
expressing these alanine mutations were examined by confocal microscopy (Fig. 4b). Mutation of His ,
Asn , or Lys to alanine did not alter the
distribution of CD44. By contrast, mutation of Leu generated a mutant protein that was expressed on the apical
plasma membrane, and mutation of Val resulted in the
majority of the protein being localized to the lateral surfaces of the
cells, with a residual proportion observed at the apical surface.
Unsurprisingly, the double mutation of Leu /Val to Ala /Ala produced a mutant with a
T- phenotype. Biochemical analysis of these point mutants (Fig. 4c) substantiated the confocal microscopy data in
that less than 5% of His mutant and greater than 95% of
the Leu and Leu /Val mutants
are detected on the apical plasma membrane. The Val mutant is the only CD44 mutation described here that clearly
exhibits a mixed phenotype with 30% of the protein detected apically
and 70% detected basolaterally.
Figure 4:
Point mutations within the HLVNK
basolateral localization sequence define critical amino acids. A series
of alanine mutations were generated in the
His -Lys sequence as described under
``Materials and Methods'' (A). Clonal lines of MDCK
cells expressing alanine point mutants were generated, and the
distribution of transfected protein was examined by confocal
microscopy. B shows vertical xz sections taken through
polarized monolayers of transfected MDCK cells cultured on Transwell
filters where human CD44 has been detected using mAb E1/2 as described
in the legend to Fig. 2. Bar = 10 µm. C shows biotinylation of CD44 on the apical and basolateral
membranes as described in the legend to Fig. 3and the percent
of transfected CD44 detected on the apical plasma membrane. The three
molecular size markers represent 116, 84, and 58 kDa. ND = not done.
The Cytoplasmic Domain of CD44 Contains a Dominant
Basolateral Localization SignalIn order to determine whether
the cytoplasmic domain of CD44 contained a dominant determinant, a
chimeric protein was generated that contained the extracellular domain
of PLAP and the transmembrane and cytoplasmic domains of human WT CD44.
Normally PLAP is found as a glycosylphosphatidylinositol-linked
glycoprotein on the apical plasma membrane(28) . PLAP 489 is a
truncated form of PLAP that is not glycosylphosphatidylinositol-tailed (29) and when expressed in MDCK cells is secreted
apically(16) . Attachment of the transmembrane and cytoplasmic
domains of WT CD44 to PLAP 489 (Fig. 5A) resulted in
PLAP being redirected to the lateral plasma membrane (Fig. 5B) such that less than 5% of the chimera was
accessible to apical biotinylation (Fig. 5C). To
demonstrate that this dominant effect was due to a specific determinant
in the cytoplasmic domain of CD44, chimeras were generated that either
lacked amino acids His -Ser or
contained the Ala /Ala mutation.
Morphological and biochemical analysis showed that these mutant
cytoplasmic domains were incapable of redirecting PLAP, resulting in
the mutant chimeras being predominantly expressed at the apical surface (Fig. 5).
Figure 5:
Distribution of PLAP/CD44 chimeric
proteins in MDCK cells. A, chimeras composed of the PLAP
extracellular domain (striped), CD44 transmembrane domain (shaded), and different CD44 cytoplasmic domain mutants (open) were generated as described under ``Materials and
Methods.'' G418-resistant mixed MDCK cell populations expressing
chimeric proteins were generated, and the distribution of transfected
protein was examined by confocal microscopy. B shows
horizontal xy (upper) vertical xz (lower) sections
taken through polarized monolayers of transfected MDCK cells cultured
on Transwell filters (see Fig. 2) using a polyclonal antiserum
directed against PLAP followed by a Texas Red-conjugated anti-rabbit
antiserum (Vector Laboratories). Bar = 10 µm. C shows the biotinylation of chimeric protein on the apical and
basolateral plasma membranes as described in Fig. 3and the
percent of chimeric protein detected on the apical plasma membrane.
Molecular size markers represent 116, 84, and 58
kDa.
DISCUSSION
Both the endogenous canine CD44 and transfected WT human CD44
are localized to the basolateral plasma membrane of polarized MDCK
epithelial cells. This distribution could result from (a)
sorting of CD44 in the trans-Golgi network (TGN) followed by direct
delivery to the basolateral membrane, (b) delivery of CD44 to
the apical plasma membrane followed by rapid and efficient transcytosis
to the basolateral plasma membrane, or (c) nonspecific
delivery to both plasma membranes followed by stabilization of CD44 at
the basolateral membrane and rapid degradation/transcytosis of apical
CD44. This latter pathway is unlikely to operate in polarized cells, as
we demonstrate here that the transmembrane/cytoplasmic domain of CD44
is capable of redirecting an apically targeted protein. This indicates
that CD44 encodes a dominant sorting signal. Mutational analysis of
a number of basolaterally localized cell surface receptors has
demonstrated the presence of dominant signals contained within their
cytoplasmic domains that mediate their direct delivery from the TGN to
the basolateral plasma membrane. For many of these proteins, such as
the nerve growth factor receptor(30, 31) ,
asialoglycoprotein receptor(32) , and low density lipoprotein
receptor (33) , there is a functional and spatial overlap of a
basolateral sorting signal with a signal required for the recruitment
of the receptors into coated pits on the plasma membrane and subsequent
endocytosis. Characteristically these overlapping signals contain an
aromatic (usually tyrosine)-X-X-large hydrophobic motif.
Secondary structure analysis suggests that such motifs can form
-turns that presumably interact with intracellular machinery
(reviewed in (34) ). In some cases the overlapping basolateral
sorting motifs and endocytosis motifs can be distinguished by
mutagenesis. For example endocytosis of lysosomal acid phosphatase is
critically dependent on the tyrosine residue in the YRHV motif, but
basolateral sorting remains efficient if this residue is substituted
for a phenylalanine(35) . This suggests that the same motif
interacts with different sets of cellular machinery which have
individual sequence and secondary structure requirements. A second
group of basolateral sorting determinants as identified in the low
density lipoprotein receptor(33) , transferrin
receptor(17) , and polymeric immunoglobulin receptor (16) are functionally and spatially separate from endocytosis
determinants. There is no clear sequence consensus within this second
group of targeting signals, although interestingly, a soluble peptide
representing the polymeric immunoglobulin receptor basolateral signal
has been shown to adopt a -type turn in solution (36) . In this study we have identified a minimal 5 amino acid basolateral
localization motif within the CD44 cytoplasmic domain. In principle
this motif could function either as a TGN sorting signal for the direct
delivery of CD44 to the basolateral membrane or as an internalization
motif required for the transcytosis of apically expressed CD44. Our
experiments do not distinguish between these two possibilities;
however, a transcytosis signal is considered unlikely for the following
reasons. Transcytosis would require CD44 to be recruited into the
coated pits, and yet in studies by Bretscher et al.(18) , it was demonstrated that CD44 (H63 in their
nomenclature) is excluded from these plasma membrane subdomains.
Supporting data for the stable residency of CD44 on the plasma membrane
comes from metabolic labeling of CD44 in MDCK cells, demonstrating that
it has a long (>24 h) half-life in these cells (14) and that
labeled anti-CD44 mAbs remain bound to CD44 on the cell surface for
>100 h without becoming
internalized(19, 20, 21) . Finally, antibody
labeling of permeabilized cells indicates that there is not a
significant pool of intracellular CD44(14, 24) . In
addition there is no precedent for resident basolateral transmembrane
proteins being routed via the apical plasma membrane in mature
polarized monolayers such as those examined here. Together, these data
suggest that the His -Lys motif
functions to sort CD44 in the TGN for subsequent delivery to the
basolateral plasma membrane. Unfortunately, the long lived nature of
CD44 combined with its extensive post-translational glycosylation
prevents the necessary metabolic pulse labeling combined with cell
surface biotinylation which would be required to directly test this. As
a consequence, the sequence motif identified in these experiments
cannot be unambiguously classified as a sorting sequence, and we
therefore refer to it as a basolateral localization motif. The
His -Lys basolateral localization
motif has no sequence similarity with the well characterized
basolateral sorting signals described above. Alanine scan mutagenesis
of this region reveals a critical dependence on the leucine residue
(Leu ) and partial dependence on the neighboring valine
residue (Val ). Recently there have been several reports
demonstrating that Leu-Z di-hydrophobic motifs (where Z is usually Leu, Ile, or Val) can play a important role
intracellular protein targeting (reviewed in (37) ). In all of
these cases, this LZ motif is associated with the endosomal
targeting of proteins from the TGN or plasma membrane. The only
exception is the Fc receptor, FcRII-B2, which has a critical dependence
on an LL motif for basolateral sorting in epithelial
cells(38, 39) ; however, unlike CD44 this motif also
mediates recruitment of FcRII-B2 into the endocytic pathway. Moreover,
both internalization and sorting of FcRII-B2 is partially dependent on
an upstream Y residue in the context of YSLL. The CD44 cytoplasmic
domain does not contain any tyrosine residues, and its single
phenylalanine residue is not conserved between species (reviewed in (22) ). The only other aromatic amino acid within the CD44
cytoplasmic domain is His that lies adjacent to the
Leu /Val motif, and mutation of this
histidine has no effect on CD44 localization (see Fig. 4). It
is not known what secondary structure the CD44 LV di-hydrophobic motif
forms. Sandoval et al.(40) have demonstrated that a
critical LI motif within the cytoplasmic tail of the lysosomal protein,
LIMP II, is held in an extended configuration and does not adopt a
-turn. Thus it remains to be determined whether the basolateral
sorting cellular machinery which recognizes -turn motifs could
also interact with di-hydrophobic motifs, such as those found in
FcRII-B2 and CD44. The second issue raised from these studies is how
the cellular machinery distinguishes between basolaterally sorted
proteins such as FcRII-B2 that are readily endocytosed and those such
as CD44 that remain as resident plasma membrane proteins. In this
respect, studies on the vesicular stomatitis virus glycoprotein are of
interest. Vesicular stomatitis virus glycoprotein utilizes a classic
Y-X-X-aliphatic motif, YTDI, to mediate its basolateral
sorting in MDCK cells, but this glycoprotein remains expressed at the
plasma membrane and is not endocytosed(41, 42) . If
common machinery is used for basolateral sorting, then resident
basolateral proteins such as vesicular stomatitis virus glycoprotein
and CD44 must either be missing additional components necessary for
efficient endocytosis and/or be subject to retention mechanisms that
would prevent recruitment into the coated pits. The cytoplasmic tail
of CD44 is highly conserved between species (reviewed in (22) )
and, as demonstrated here, is necessary for the correct plasma membrane
localization of this molecule. In addition, this intracellular domain
of CD44 can regulate ligand binding as cells expressing truncated CD44
mutants exhibit reduced or abolished ability to bind
hyaluronan(43, 44, 45, 46) .
Although there is dispute in the literature as to whether ligand
binding is regulated by a discrete domain, there is general agreement
that truncation of the CD44 cytoplasmic domain upstream of the
basolateral localization sequence identified here does not alter its
ability to associate with hyaluronan (44, 46, 47, 48) . Similarly, this
basolateral localization sequence appears to be functionally and
spatially distinct from the transmembrane domain of CD44 that regulates
the Triton X-100 solubility of this receptor (14, 49, 53) and from the two phosphorylation
sites, Ser and Ser (24) . There are
reports in the literature that di-hydrophobic motifs might function in
the context of upstream phosphorylation events, for example to enhance
the internalization of CD4(50) . However, mutation of the
Ser and Ser phosphorylation sites does not
disrupt the basolateral localization of CD44 (24) nor reduce
the half-life of the protein (data not shown). This WT distribution of
the CD44 phosphorylation mutants also strengthens the suggestion that
CD44 is not rapidly transcytosed from the apical membrane given that at
least in some cases transcytosis is known to be a phosphorylation
dependent mechanism(51) . To understand how these different
domains of CD44 regulate function, it will be necessary to identify
both cytoplasmic and membrane components with which these individual
receptor domains interact. Finally, the lateral plasma membrane
distribution of CD44 in simple epithelial cells suggests a role for
CD44 in interepithelial interactions. There is increasing evidence that
this interaction may operate in a hyaluronan-independent manner, and
therefore identification of novel ligands will be crucial in
elucidating mechanisms controlling this important transmembrane
receptor.
FOOTNOTES
- *
- This work was supported by grants from
the Medical Research Campaign and the Cancer Research Campaign. The
costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
- §
- To whom correspondence should be addressed. h.sheikh{at}ic.ac.uk.
- (
) - The
abbreviations used are: T-, tailless; bp, base pair(s); WT, wild type;
MDCK, Madin-Darby canine kidney; mAb, monoclonal antibody; PLAP,
placental alkaline phosphatase; TGN, trans-Golgi network.
ACKNOWLEDGEMENTS
We thank Sidney Udenfriend, Keith Mostov, and Gerald
Apodaca for advice and for providing the PLAP constructs. We also thank
David Peck and Stephen Neame for help with the experiments and Mark
Marsh and Caroline Uff for critical reading of the manuscript.
REFERENCES
- Lesley, J., Hyman, R.,
and Kincade, P. W. (1993) Adv. Immunol. 54, 271-335
[Medline]
[Order article via Infotrieve]
- Sherman, L., Sleeman, J.,
Herrlich, P., and Ponta, H. (1994) Curr. Opin. Cell
Biol. 6, 726-733
[CrossRef][Medline]
[Order article via Infotrieve]
- Alho, A. M., and
Underhill, C. B. (1989) J. Cell Biol. 108, 1557-1565
[Abstract/Free Full Text]
- Haggerty, J. G., Bretton,
R. H., and Milstone, L. M. (1992) J. Invest. Dermatol. 99, 374-380
[CrossRef][Medline]
[Order article via Infotrieve]
- Wang, C., Tammi, M., and
Tammi, R. (1992) Histochemistry 98, 105-112
[CrossRef][Medline]
[Order article via Infotrieve]
- Milstone, L. M.,
Hough-Monroe, L., Kugelman, L. C., Bender, J. R., and Haggerty, J. G. (1994) J. Cell Sci. 107, 3183-3190
[Abstract]
- Hudson, D. L., Sleeman,
J., and Watt, F. M. (1995) J. Cell Sci. 108, 1959-1970
[Abstract]
- Simons, K., and Fuller,
S. D. (1985) Annu. Rev. Cell Biol. 1, 243-288
[CrossRef]
- Rodriguez-Boulan, E., and
Nelson, W. J. (1989) Science 245, 718-725
[Abstract/Free Full Text]
- Simons, K., and
Wandinger-Ness, A. (1990) Cell 62, 207-210
[CrossRef][Medline]
[Order article via Infotrieve]
- Mostov, K. E.. Apodaca,
G., Aroeti, B., and Okamoto, C. (1992) J. Cell Biol. 116, 577-583
[Free Full Text]
- Matter, K., and Mellman,
I. (1994) Curr. Opin. Cell Biol. 6, 545-554
[CrossRef][Medline]
[Order article via Infotrieve]
- Mostov, K. E., and
Cardone, M. H. (1995) Bioessays 17, 129-138
[CrossRef][Medline]
[Order article via Infotrieve]
- Neame, S. J., and
Isacke, C. M. (1993) J. Cell Biol. 121, 1299-1310
[Abstract/Free Full Text]
- Hunziker, W., Harter,
C., Matter, K., and Mellman, I. (1991) Cell 66, 907-920
[CrossRef][Medline]
[Order article via Infotrieve]
- Casanova, J. E.,
Apodaca, G., and Mostov, K. E. (1991) Cell 66, 65-75
[CrossRef][Medline]
[Order article via Infotrieve]
- Dargemont, C., Le Bivic,
A., Rothenberger, S., Iacopetta, B., and Kühn, L.
C. (1993) EMBO J. 12, 1713-1721
[Medline]
[Order article via Infotrieve]
- Bretscher, M. S.,
Thomson, J. N., and Pearse, B. M. F. (1980) Proc.
Natl. Acad. Sci. U. S. A. 77, 4156-4159
[Abstract/Free Full Text]
- Jacobson, K.,
O'Dell, D., Holifield, B., Murphy, T. L., and August, J. T. (1984) J. Cell Biol. 99, 1613-1623
[Abstract/Free Full Text]
- Jacobson, K.,
O'Dell, D., and August, J. T. (1984) J. Cell
Biol. 99, 1624-1633
[Abstract/Free Full Text]
- Ishihara, A., Holifield,
B., and Jacobson, K. (1988) J. Cell Biol. 106, 329-343
[Abstract/Free Full Text]
- Isacke, C. M. (1994) J. Cell Sci. 107, 2353-2359
[Medline]
[Order article via Infotrieve]
- Screaton, G. R., Bell,
M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 12160-12164
[Abstract/Free Full Text]
- Neame, S. J., and
Isacke, C. M. (1992) EMBO J. 11, 4733-4738
[Medline]
[Order article via Infotrieve]
- Millan, J. L. (1986) J. Biol. Chem. 261, 3112-3115
[Abstract/Free Full Text]
- Screaton, G. R., Bell,
M. V., Bell, J. I., and Jackson, D. G. (1993) J. Biol.
Chem. 268, 12235-12238
[Abstract/Free Full Text]
- Stamenkovic, I., Amiot,
M., Pesando, J. M., and Seed, B. (1989) Cell 56, 1057-1062
[CrossRef][Medline]
[Order article via Infotrieve]
- Brown, D. A., Crise, B.,
and Rose, J. K. (1989) Science 245, 1499-1501
[Abstract/Free Full Text]
- Berger, J., Howard, A.
D., Brink, L., Gerber, L., Hauber, J., Cullen, B. R., and Udenfriend,
S. (1988) J. Biol. Chem. 263, 10016-10021
[Abstract/Free Full Text]
- Le Bivic, A., Sambuy,
Y., Patzak, A., Patil, N., Chao, M., and Rodriguez-Boulan, E. (1991) J. Cell Biol. 115, 607-618
[Abstract/Free Full Text]
- Monlauzeur, L.,
Rajasekaran, A., Chao, M., Rodriguez-Boulan, E., and Le Bivic, A. (1995) J. Biol. Chem. 270, 12219-12225
[Abstract/Free Full Text]
- Geffen, I., Fuhrer, C.,
Leitinger, B., Weiss, M., Huggel, K., Griffiths, G., and Spiess, M. (1993) J. Biol. Chem. 268, 20772-20777
[Abstract/Free Full Text]
- Matter, K., Hunziker,
W., and Mellman, I. (1992) Cell 71, 741-753
[CrossRef][Medline]
[Order article via Infotrieve]
- Vaux, D. (1992) Trends Cell Biol. 2, 189-192
[CrossRef][Medline]
[Order article via Infotrieve]
- Prill, V., Lehmann, L.,
von Figura, K., and Peters, C. (1993) EMBO J. 12, 2181-2193
[Medline]
[Order article via Infotrieve]
- Aroeti, B., Kosen, P.
A., Kuntz, I. D., Cohen, F. E., and Mostov, K. E. (1993) J. Cell Biol. 123, 1149-1160
[Abstract/Free Full Text]
- Sandoval, I. V., and
Bakke, O. (1994) Trends Cell Biol. 4, 292-297
[CrossRef][Medline]
[Order article via Infotrieve]
- Hunziker, W., and Fumey,
C. (1994) EMBO J. 13, 2963-2969
[Medline]
[Order article via Infotrieve]
- Matter, K., Yamamoto, E.
M., and Mellman, I. (1994) J. Cell Biol. 126, 991-1004
[Abstract/Free Full Text]
- Sandoval, I. V.,
Arrendondo, J. J., Alcalde, J., Noriega, A. G., Vandekerckhove, J.,
Jimenez, M. A., and Rico, M. (1994) J. Biol. Chem. 269, 6622-6631
[Abstract/Free Full Text]
- Thomas, D. C., Brewer,
C. B., and Roth, M. G. (1993) J. Biol. Chem. 268, 3313-3320
[Abstract/Free Full Text]
- Thomas, D. C., and Roth,
M. G. (1994) J. Biol. Chem. 269, 15732-15739
[Abstract/Free Full Text]
- Lesley, J., Schulte, R.,
and Hyman, R. (1990) Exp. Cell Res. 187, 224-233
[CrossRef][Medline]
[Order article via Infotrieve]
- Lokeshwar, V. B.,
Fregien, N., and Bourguignon, L. Y. W. (1994) J. Cell
Biol. 126, 1099-1109
[Abstract/Free Full Text]
- Uff, C. R., Neame, S.
J., and Isacke, C. M. (1995) Eur. J. Immunol. 25, 1883-1887
[Medline]
[Order article via Infotrieve]
- Perschl, A., Lesley, J.,
English, N., Trowbridge, I., and Hyman, R. (1995) Eur.
J. Immunol. 25, 495-501
[Medline]
[Order article via Infotrieve]
- Liao, H.-X., Levesque,
M. C., Patton, K., Bergamo, B., Jones, D., Moody, M. A., Telen, M. J.,
and Haynes, B. F. (1993) J. Immunol. 151, 6490-6499
[Abstract]
- Puré,
E., Camp, R. L., Peritt, D., Panettieri, R. A., Jr., Lazaar, A. L., and
Nayak, S. (1995) J. Exp. Med. 181, 55-62
[Abstract/Free Full Text]
- Neame, S. J., Uff, C.
R., Sheikh, H., Wheatley, S. C., and Isacke, C. M. (1995) J. Cell Sci. 108, 3127-3135
[Abstract]
- Shin, J., Dunbrack, R.
L., Jr., Lee, S., and Strominger, J. L. (1991) J.
Biol. Chem. 266, 10658-10665
[Abstract/Free Full Text]
- Casanova, J. E.,
Breitfeld, P. P., Ross, S. A., and Mostov, K. E. (1990) Science 248, 742-745
[Abstract/Free Full Text]
- Milde, K. F., Alejandro,
R., and Pastori, R. L. (1994) Immunogenetics 40, 437-444
[Medline]
[Order article via Infotrieve]
- Perschl, A., Lesley, J.,
English, N., Hyman, R., and Trowbridge, I. S. (1995) J. Cell Sci. 108, 1033-1041
[Abstract]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J.-L. Lee, M.-J. Wang, and J.-Y. Chen
Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
J. Cell Biol.,
June 15, 2009;
185(6):
949 - 957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kato, S. Khan, E. d'Aniello, K. J. McDonald, and D. N. J. Hart
The Novel Endocytic and Phagocytic C-Type Lectin Receptor DCL-1/CD302 on Macrophages Is Colocalized with F-Actin, Suggesting a Role in Cell Adhesion and Migration
J. Immunol.,
November 1, 2007;
179(9):
6052 - 6063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Li, E. Y. Li, L. Neumeier, L. Conforti, and M. Soleimani
Identification of a novel signal in the cytoplasmic tail of the Na+:HCO3- cotransporter NBC1 that mediates basolateral targeting
Am J Physiol Renal Physiol,
April 1, 2007;
292(4):
F1245 - F1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wild-Bode, K. Fellerer, J. Kugler, C. Haass, and A. Capell
A Basolateral Sorting Signal Directs ADAM10 to Adherens Junctions and Is Required for Its Function in Cell Migration
J. Biol. Chem.,
August 18, 2006;
281(33):
23824 - 23829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanemoto, T. Abe, and S. Ito
PDZ-Binding and Di-Hydrophobic Motifs Regulate Distribution of Kir4.1 Channels in Renal Cells
J. Am. Soc. Nephrol.,
September 1, 2005;
16(9):
2608 - 2614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Iverson, D. Fox III, L. S. Nadler, R. E. Klevit, and N. M. Nathanson
Identification and Structural Determination of the M3 Muscarinic Acetylcholine Receptor Basolateral Sorting Signal
J. Biol. Chem.,
July 1, 2005;
280(26):
24568 - 24575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Deora, D. Gravotta, G. Kreitzer, J. Hu, D. Bok, and E. Rodriguez-Boulan
The Basolateral Targeting Signal of CD147 (EMMPRIN) Consists of a Single Leucine and Is Not Recognized by Retinal Pigment Epithelium
Mol. Biol. Cell,
September 1, 2004;
15(9):
4148 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Sundberg, N. Beauchemin, and B. Obrink
The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells
J. Cell Sci.,
March 1, 2004;
117(7):
1091 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Thorne, J. W. Legg, and C. M. Isacke
The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events
J. Cell Sci.,
January 22, 2004;
117(3):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Rajasekaran, G. Anilkumar, E. Oshima, J. U. Bowie, H. Liu, W. Heston, N. H. Bander, and A. K. Rajasekaran
A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen
Mol. Biol. Cell,
December 1, 2003;
14(12):
4835 - 4845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Chellaiah, R. S. Biswas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska
Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in Osteoclasts
J. Biol. Chem.,
August 1, 2003;
278(31):
29086 - 29097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kizhatil and L. M. Albritton
System y+ localizes to different membrane subdomains in the basolateral plasma membrane of epithelial cells
Am J Physiol Cell Physiol,
December 1, 2002;
283(6):
C1784 - C1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Suemizu, M. Radosavljevic, M. Kimura, S. Sadahiro, S. Yoshimura, S. Bahram, and H. Inoko
A basolateral sorting motif in the MICA cytoplasmic tail
PNAS,
February 14, 2002;
(2002)
52701099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bello, J. W. Goding, V. Greengrass, A. Sali, V. Dubljevic, C. Lenoir, G. Trugnan, and M. Maurice
Characterization of a Di-leucine-based Signal in the Cytoplasmic Tail of the Nucleotide-pyrophosphatase NPP1 That Mediates Basolateral Targeting but not Endocytosis
Mol. Biol. Cell,
October 1, 2001;
12(10):
3004 - 3015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Gouyer, E Leteurtre, P Delmotte, W. Steelant, M. Krzewinski-Recchi, J. Zanetta, T Lesuffleur, G Trugnan, P Delannoy, and G Huet
Differential effect of GalNAc(&agr;)-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern
J. Cell Sci.,
January 4, 2001;
114(8):
1455 - 1471.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H Sheikh, H Yarwood, A Ashworth, and C. Isacke
Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor
J. Cell Sci.,
January 3, 2000;
113(6):
1021 - 1032.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. El Nemer, Y. Colin, C. Bauvy, P. Codogno, R. H. Fraser, J. P. Cartron, and C. L. Van Kim
Isoforms of the Lutheran/Basal Cell Adhesion Molecule Glycoprotein Are Differentially Delivered in Polarized Epithelial Cells. MAPPING OF THE BASOLATERAL SORTING SIGNAL TO A CYTOPLASMIC DI-LEUCINE MOTIF
J. Biol. Chem.,
November 5, 1999;
274(45):
31903 - 31908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oliferenko, K. Paiha, T. Harder, V. Gerke, C. Schwarzler, H. Schwarz, H. Beug, U. Gunthert, and L. A. Huber
Analysis of CD44-containing Lipid Rafts: Recruitment of Annexin II and Stabilization by the Actin Cytoskeleton
J. Cell Biol.,
August 23, 1999;
146(4):
843 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kachinsky, S. C. Froehner, and S. L. Milgram
A PDZ-containing Scaffold Related to the Dystrophin Complex at the Basolateral Membrane of Epithelial Cells
J. Cell Biol.,
April 19, 1999;
145(2):
391 - 402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Simmen, M. Nobile, J. S. Bonifacino, and W. Hunziker
Basolateral Sorting of Furin in MDCK Cells Requires a Phenylalanine-Isoleucine Motif Together with an Acidic Amino Acid Cluster
Mol. Cell. Biol.,
April 1, 1999;
19(4):
3136 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schülein, R. Hermosilla, A. Oksche, M. Dehe, B. Wiesner, G. Krause, and W. Rosenthal
A Dileucine Sequence and an Upstream Glutamate Residue in the Intracellular Carboxyl Terminus of the Vasopressin V2 Receptor Are Essential for Cell Surface Transport in COS.M6 Cells
Mol. Pharmacol.,
September 1, 1998;
54(3):
525 - 535.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Geisler, J. Dietrich, B. L. Nielsen, J. Kastrup, J. P. H. Lauritsen, N. Odum, and M. D. Christensen
Leucine-based Receptor Sorting Motifs Are Dependent on the Spacing Relative to the Plasma Membrane
J. Biol. Chem.,
August 14, 1998;
273(33):
21316 - 21323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Beau, M.-T. Groyer-Picard, A. Le Bivic, B. Vannier, H. Loosfelt, E. Milgrom, and M. Misrahi
The Basolateral Localization Signal of the Follicle-stimulating Hormone Receptor
J. Biol. Chem.,
July 17, 1998;
273(29):
18610 - 18616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dietrich, J. Kastrup, B. L. Nielsen, N. Odum, and C. Geisler
Regulation and Function of the CD3gamma DxxxLL Motif: A Binding Site for Adaptor Protein-1 and Adaptor Protein-2 in Vitro
J. Cell Biol.,
July 28, 1997;
138(2):
271 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Odorizzi and I. S. Trowbridge
Structural Requirements for Major Histocompatibility Complex Class II Invariant Chain Trafficking in Polarized Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
May 2, 1997;
272(18):
11757 - 11762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. V. Sandoval, S. Martinez-Arca, J. Valdueza, S. Palacios, and G. D. Holman
Distinct Reading of Different Structural Determinants Modulates the Dileucine-mediated Transport Steps of the Lysosomal Membrane Protein LIMPII and the Insulin-sensitive Glucose Transporter GLUT4
J. Biol. Chem.,
December 15, 2000;
275(51):
39874 - 39885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-Q. Sun, M. A. Arrese, L. Zeng, I'K. Swaby, M.-M. Zhou, and F. J. Suchy
The Rat Liver Na+/Bile Acid Cotransporter. IMPORTANCE OF THE CYTOPLASMIC TAIL TO FUNCTION AND PLASMA MEMBRANE TARGETING
J. Biol. Chem.,
February 23, 2001;
276(9):
6825 - 6833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Miranda, T. Khromykh, P. Christy, T. L. Le, C. J. Gottardi, A. S. Yap, J. L. Stow, and R. D. Teasdale
A Dileucine Motif Targets E-cadherin to the Basolateral Cell Surface in Madin-Darby Canine Kidney and LLC-PK1 Epithelial Cells
J. Biol. Chem.,
June 15, 2001;
276(25):
22565 - 22572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Suemizu, M. Radosavljevic, M. Kimura, S. Sadahiro, S. Yoshimura, S. Bahram, and H. Inoko
A basolateral sorting motif in the MICA cytoplasmic tail
PNAS,
March 5, 2002;
99(5):
2971 - 2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|